- Report
- February 2024
Argentina
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Kazakhstan
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Costa Rica
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Bangladesh
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Switzerland
From €2238EUR$2,500USD£1,906GBP
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Philippines
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
New Zealand
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Netherlands
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
El Salvador
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
South Africa
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Czech Republic
From €2238EUR$2,500USD£1,906GBP
From €2238EUR$2,500USD£1,906GBP
From €2238EUR$2,500USD£1,906GBP
- Report
- February 2024
Global, Europe, United States, ... Global, Europe, United States, Japan
From €16561EUR$18,500USD£14,106GBP
- Report
- February 2024
Canada, Mexico, North America Canada, Mexico, North America
From €8504EUR$9,500USD£7,244GBP
- Report
- February 2024
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €11190EUR$12,500USD£9,531GBP
- Report
- August 2022
Asia Pacific
From €12980EUR$14,500USD£11,056GBP
- Report
- August 2022
Latin America
From €12980EUR$14,500USD£11,056GBP
- Report
- July 2022
Global
From €31332EUR$35,000USD£26,688GBP

The Thrombin Time test is a coagulation and hemostasis test used to measure the time it takes for a clot to form in a sample of blood. It is used to detect deficiencies in the coagulation cascade, such as those caused by heparin, fibrinogen, or factor deficiencies. The test is also used to monitor the effectiveness of anticoagulant therapy.
The Thrombin Time market is a subset of the larger coagulation and hemostasis testing market. It is a growing market, driven by the increasing prevalence of cardiovascular diseases, as well as the need for more accurate and reliable testing methods. The market is expected to benefit from the development of new technologies and products, such as automated systems and point-of-care testing.
Some of the major companies in the Thrombin Time market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, and Ortho Clinical Diagnostics. Show Less Read more